Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | fructose-bisphosphate aldolase 2 | 0.0618 | 0.3531 | 0.4989 |
Trichomonas vaginalis | mannosyltransferase 1, putative | 0.0139 | 0.068 | 1 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0618 | 0.3531 | 0.8169 |
Brugia malayi | Ryanodine Receptor TM 4-6 family protein | 0.0885 | 0.5121 | 0.5114 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0352 | 0.0498 |
Loa Loa (eye worm) | fructose-bisphosphate aldolase 1 | 0.0618 | 0.3531 | 0.4989 |
Mycobacterium ulcerans | glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.5 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0633 | 0.3621 | 1 |
Trypanosoma brucei | fructose-bisphosphate aldolase, glycosomal, putative | 0.0618 | 0.3531 | 0.8169 |
Loa Loa (eye worm) | hypothetical protein | 0.1214 | 0.7078 | 1 |
Onchocerca volvulus | 0.0139 | 0.068 | 1 | |
Brugia malayi | fructose-bisphosphate aldolase 2 | 0.0618 | 0.3531 | 0.3521 |
Leishmania major | trypanothione reductase | 0.0064 | 0.0237 | 0.0386 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.1256 | 0.1774 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0064 | 0.0237 | 0.0386 |
Schistosoma mansoni | ryanodine receptor related | 0.0885 | 0.5121 | 0.597 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0352 | 0.0498 |
Brugia malayi | MIR domain containing protein | 0.0139 | 0.068 | 0.0666 |
Echinococcus granulosus | stromal cell derived factor 2 | 0.0139 | 0.068 | 0.161 |
Loa Loa (eye worm) | hypothetical protein | 0.0044 | 0.0116 | 0.0163 |
Plasmodium falciparum | glutathione reductase | 0.0064 | 0.0237 | 0.0386 |
Loa Loa (eye worm) | Plcb4 protein | 0.0098 | 0.0439 | 0.0621 |
Loa Loa (eye worm) | ryanodine receptor | 0.0239 | 0.1277 | 0.1804 |
Brugia malayi | Variant SH3 domain containing protein | 0.0047 | 0.0137 | 0.0122 |
Brugia malayi | fructose-bisphosphate aldolase 1 | 0.0618 | 0.3531 | 0.3521 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0045 | 0.012 | 0.0106 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0618 | 0.3531 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0064 | 0.0237 | 0.0386 |
Brugia malayi | phospholipase C homolog | 0.0074 | 0.0294 | 0.028 |
Toxoplasma gondii | fructose-1,6-bisphosphate aldolase | 0.0618 | 0.3531 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0633 | 0.3621 | 0.5116 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0382 | 0.2126 | 0.2398 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0618 | 0.3531 | 0.8169 |
Loa Loa (eye worm) | hypothetical protein | 0.1072 | 0.6234 | 0.8808 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Plasmodium vivax | glucose-6-phosphate isomerase, putative | 0.0044 | 0.0116 | 0.003 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0074 | 0.0294 | 0.0213 |
Plasmodium falciparum | fructose-bisphosphate aldolase | 0.0618 | 0.3531 | 1 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Onchocerca volvulus | 0.0135 | 0.0656 | 0.8948 | |
Echinococcus multilocularis | stromal cell derived factor 2 | 0.0139 | 0.068 | 0.161 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0064 | 0.0237 | 0.0335 |
Loa Loa (eye worm) | glutathione reductase | 0.0064 | 0.0237 | 0.0335 |
Echinococcus granulosus | 1-Phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-4 | 0.0101 | 0.0454 | 0.0967 |
Leishmania major | fructose-1,6-bisphosphate aldolase | 0.0618 | 0.3531 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0382 | 0.2126 | 0.3004 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0064 | 0.0237 | 0.0347 |
Plasmodium vivax | fructose 1,6-bisphosphate aldolase, putative | 0.0618 | 0.3531 | 1 |
Loa Loa (eye worm) | phosphoglucose isomerase | 0.0044 | 0.0116 | 0.0163 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0382 | 0.2126 | 0.5736 |
Echinococcus granulosus | fructose bisphosphate aldolase class I | 0.0618 | 0.3531 | 0.9743 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.0618 | 0.3531 | 0.4073 |
Loa Loa (eye worm) | hypothetical protein | 0.0135 | 0.0656 | 0.0927 |
Leishmania major | hypothetical protein, conserved | 0.0507 | 0.2874 | 0.8083 |
Loa Loa (eye worm) | MIR domain-containing protein | 0.0139 | 0.068 | 0.0961 |
Plasmodium falciparum | thioredoxin reductase | 0.0064 | 0.0237 | 0.0386 |
Plasmodium falciparum | glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.003 |
Echinococcus granulosus | cytohesin 1 | 0.0093 | 0.0405 | 0.0827 |
Loa Loa (eye worm) | cytohesin 3 | 0.0093 | 0.0405 | 0.0573 |
Loa Loa (eye worm) | hypothetical protein | 0.1197 | 0.6981 | 0.9863 |
Trypanosoma cruzi | inositol 1,4,5-trisphosphate receptor, putative | 0.0746 | 0.4296 | 1 |
Brugia malayi | Cytohesin 3 | 0.0093 | 0.0405 | 0.0391 |
Leishmania major | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0084 | 0.0352 | 0.0721 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0084 | 0.0352 | 0.0566 |
Brugia malayi | Thioredoxin reductase | 0.0064 | 0.0237 | 0.0223 |
Trypanosoma cruzi | phosphoinositide-specific phospholipase C, putative | 0.0045 | 0.012 | 0.0011 |
Toxoplasma gondii | thioredoxin reductase | 0.0064 | 0.0237 | 0.0357 |
Echinococcus multilocularis | serotonin receptor | 0.0382 | 0.2126 | 0.5736 |
Echinococcus multilocularis | cytohesin 1 | 0.0093 | 0.0405 | 0.0827 |
Schistosoma mansoni | guanyl-nucleotide exchange factor | 0.0093 | 0.0405 | 0.0346 |
Loa Loa (eye worm) | variant SH3 domain-containing protein | 0.0047 | 0.0137 | 0.0194 |
Toxoplasma gondii | phosphoinositide phospholipase PIPLC | 0.0045 | 0.012 | 0.0014 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Brugia malayi | 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta 4 | 0.0098 | 0.0439 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.0382 | 0.2126 | 0.3004 |
Leishmania major | glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.003 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.1072 | 0.6234 | 0.7298 |
Echinococcus multilocularis | serotonin receptor | 0.0382 | 0.2126 | 0.5736 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0633 | 0.3621 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0064 | 0.0237 | 1 |
Echinococcus granulosus | fructose 16 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Mycobacterium leprae | Probable glucose-6-phosphate isomerase Pgi (phosphoglucose isomerase) (phosphohexose isomerase) (PHI) | 0.0044 | 0.0116 | 0.5 |
Trypanosoma brucei | inositol 1,4,5-trisphosphate receptor | 0.0746 | 0.4296 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0064 | 0.0237 | 0.0291 |
Echinococcus multilocularis | fructose bisphosphate aldolase class I | 0.0618 | 0.3531 | 0.9743 |
Schistosoma mansoni | phospholipase C-like protein 2 plc-L2 | 0.0162 | 0.0816 | 0.0836 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0105 | 0.0149 |
Schistosoma mansoni | phospholipase C beta | 0.0098 | 0.0439 | 0.0386 |
Trypanosoma brucei | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0087 | 0.0375 | 0.0622 |
Loa Loa (eye worm) | hypothetical protein | 0.0101 | 0.0454 | 0.0642 |
Treponema pallidum | glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.5 |
Leishmania major | phospholipase c-like protein | 0.0045 | 0.012 | 0.0044 |
Echinococcus granulosus | ryanodine receptor 44f | 0.0491 | 0.2777 | 0.7593 |
Echinococcus multilocularis | fructose 1,6 bisphosphate aldolase | 0.0618 | 0.3531 | 0.9743 |
Toxoplasma gondii | fructose-bisphosphate aldolase, putative | 0.0618 | 0.3531 | 1 |
Trypanosoma brucei | phosphoinositide-specific phospholipase C | 0.0045 | 0.012 | 0.0011 |
Loa Loa (eye worm) | hypothetical protein | 0.0084 | 0.0352 | 0.0498 |
Brugia malayi | glucose phosphate isomerase a | 0.0044 | 0.0116 | 0.0101 |
Echinococcus multilocularis | 1 phosphatidylinositol 4,5 bisphosphate | 0.0101 | 0.0454 | 0.0967 |
Trypanosoma brucei | trypanothione reductase | 0.0064 | 0.0237 | 0.0291 |
Giardia lamblia | Glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.5 |
Schistosoma mansoni | ryanodine receptor 1 skeletal muscle | 0.0239 | 0.1277 | 0.1385 |
Echinococcus multilocularis | ryanodine receptor 44f | 0.0491 | 0.2777 | 0.7593 |
Trypanosoma cruzi | inositol-1,4,5-trisphosphate (IP3) 5-phosphatase, putative | 0.0084 | 0.0352 | 0.0566 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0064 | 0.0237 | 0.0347 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0618 | 0.3531 | 0.8169 |
Chlamydia trachomatis | glucose-6-phosphate isomerase | 0.0044 | 0.0116 | 0.5 |
Brugia malayi | Phosphatidylinositol-specific phospholipase C, X domain containing protein | 0.0042 | 0.0105 | 0.0091 |
Schistosoma mansoni | inositol 145-trisphosphate receptor | 0.1453 | 0.85 | 1 |
Loa Loa (eye worm) | phosphatidylinositol-specific phospholipase C | 0.0045 | 0.012 | 0.017 |
Brugia malayi | glutathione reductase | 0.0064 | 0.0237 | 0.0223 |
Entamoeba histolytica | MIR domain protein | 0.0139 | 0.068 | 1 |
Schistosoma mansoni | fructose 16-bisphosphate aldolase | 0.0618 | 0.3531 | 0.4073 |
Schistosoma mansoni | stromal cell-derived factor 2 precursor-like protein | 0.0139 | 0.068 | 0.0673 |
Trypanosoma cruzi | fructose-bisphosphate aldolase, glycosomal, putative | 0.0618 | 0.3531 | 0.8169 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 78 uM | In vitro inhibition of lysosomal phospholipase activity for release of labeled lysophosphatidylcholine | ChEMBL. | 2016725 |
IC50 (binding) | = 78 uM | In vitro inhibition of lysosomal phospholipase activity for release of labeled lysophosphatidylcholine | ChEMBL. | 2016725 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.